| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |